Knockdown of PPAR δ Gene Promotes the Growth of Colon Cancer and Reduces the Sensitivity to Bevacizumab in Nude Mice Model

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Yang, Lie ^a   Zhou, Jin ^a   Ma, Qin ^a   Wang, Cun ^a   Chen, Keling ^a   Meng, Wenjian ^a   Yu, Yongyang ^a   Zhou, Zongguang ^a   Sun, Xiaofeng ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, NUDE; PPAR GAMMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS MUSCULUS;

EID: 84876007745     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060715     Document Type: Article

References (26)

1. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, et al. (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Nat Acad Sci USA 91: 7355-7359.
2. Uhlén M, Björling E, Agaton C, Szigyarto CA, Amini B, et al. (2005) A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 4: 1920-1932.
3. Berglund L, Björling E, Oksvold P, Fagerberg L, Asplund A, http://mcponline.org/search?author1=AnjaPersson&sortspec=date&submit=Submitet al. (2008) A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol Cell Proteomics 7: 2019-2027.
4. Girroir EE, Hollingshead HE, He P, Zhu B, Perdew GH, et al. (2008) Quantitative expression patterns of Peroxisome proliferator-activated receptor-b/d (PPARb/d) protein in mice. Biochem Biophys Res Commun 371: 456-461.
5. Lee CH, Olson P, Hevener A, Mehl I, Chong LW, et al. (2006) PPARd regulates glucose metabolism and insulin sensitivity. Proc Nat Acad Sci USA 103: 3444-49.
6. Grimaldi PA, (2010) Metabolic and nonmetabolic regulatory functions of peroxisome proliferator-activated receptor b. Curr Opin Lipidol 21: 186-191.
7. Peters JM, Gonzalez FJ, (2009) Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer. Biochim Biophys Acta 1796: 230-241.
8. Kota BP, Huang TH, Roufogalis BD, (2005) An overview on biological mechanisms of PPARs. Pharmacol Res 51: 85-94.
9. Yang L, Zhang H, Zhou ZG, Yan H, Adell G, et al. (2011) Biological function and prognostic significance of peroxisome proliferator-activated receptor {delta} in rectal cancer. Clin Cancer Res 17: 3760-3770.
10. Yang L, Olsson B, Pfeifer D, Jönsson JI, Zhou ZG, et al. (2010) Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells. Oncogene 29: 516-526.
11. Yang L, Zhou ZG, Luo HZ, Zhou B, Xia QJ, et al. (2006) Quantitative analysis of PPARdelta mRNA by real-time RT-PCR in 86 rectal cancer tissues. Eur J Surg Oncol 2: 181-185.
12. Harman FS, Nicol CJ, Marin HE, Ward JM, Gonzalez FJ, et al. (2004) Peroxisome proliferator-activated receptor-δ attenuates colon carcinogenesis. Nat Med 10: 481-483.
13. Holly EH, Borland MG, Billin AN, Willson TM, Gonzalez FJ, et al. (2008) Ligand activation of peroxisome proliferator-activated receptor-b/d (PPARb/d) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms. Carcinogenesis 29: 169-176.
14. Park BH, Vogelstein B, Kinzler KW, (2001) Genetic disruption of PPARd decreases the tumorigenicity of human colon cancer cells. Proc Nat Acad Sci USA 98: 2598-2603.
15. Barak Y, Liao D, He W, Ong ES, Nelson MC, et al. (2002) Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci U S A 8: 303-8.
16. Schmuth M, Haqq CM, Cairns WJ, Holder JC, Dorsam S, et al. (2004) Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol 122: 971-983.
17. Burdick AD, Kim DJ, Peraza MA, Gonzalez FJ, Peters JM, (2006) The role of peroxisome proliferator-activated receptor-β/δ in epithelial cell growth and differentiation. Cell Signal 18: 9-20.
18. Kim DJ, Bility MT, Billin AN, Willson TM, Gonzalez FJ, et al. (2006) PPARβ/δ selectively induces differentiation and inhibits cell proliferation. Cell Death Differ 13: 53-60.
19. Varnat F, Heggeler BB, Grisel P, Boucard N, Corthésy-Theulaz I, et al. (2006) PPARβ/δ regulates paneth cell differentiation via controlling the hedgehog signaling pathway. Gastroenterology 131: 538-553.
20. Yang L, Zhou ZG, Zheng XL, Wang L, Yu YY, et al. (2008) RNA interference against peroxisome proliferator-activated receptor δ gene promotes proliferation of human colorectal cancer cells. Dis Colon Rectum 51: 318-26.
21. Gupta RA, Dubois RN, (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1: 11-21.
22. Hanahan D, Folkman J, (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
23. Bergsland EK, (2004) Vascular endothelial growth factor as a therapeutic target in cancer. Am J Health Syst Pharm 61: S4-S11.
24. Wang D, Wang H, Guo Y, Ning W, Katkuri S, et al. (2006) Crosstalk between Peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression. Proc Nat Acad Sci USA 103: 19069-19074.
25. Lin H, Lee JL, Hou HH, Chung CP, Hsu SP, et al. (2008) Molecular mechanisms of the antiproliferative effect of beraprost, a prostacyclin agonist, in murine vascular smooth muscle cells. J Cell Physiol 214: 434-441.
26. Lim HJ, Lee S, Park JH, Lee KS, Choi HE, et al. (2009) PPAR δ agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle. Atherosclerosis 202: 446-454.